Search Within

Marc Ladanyi

Formats
  1. Journal Article (653)
  2. Meeting Abstract (644)
  3. Book Section (13)
  4. Research Letter (8)
  5. Review (7)
  6. Editorial (5)
  7. Guidelines (3)
  8. Conference Paper (1)
  9. Correspondence (1)
  10. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (1336)
  2. GSK Faculty (1336)
  3. Human Oncology and Pathogenesis Program (1336)
  4. Tow Center for Developmental Oncology (TCDO) (1336)
  5. Department of Medicine (647)
  6. Solid Tumor Oncology Division (618)

More Groups

People
  1. Maria Arcila (303)
  2. Michael Berger (220)
  3. Mark Kris (191)
  4. Gregory Riely (188)
  5. Ahmet Zehir (178)
  6. Natasha Rekhtman (134)

More People

Years
  1. 2025 (23)
  2. 2024 (37)
  3. 2023 (48)
  4. 2022 (72)
  5. 2021 (62)
  6. 2020 (63)

More Years

Publications
  1. Modern Pathology (189)
  2. Laboratory Investigation (155)
  3. Journal of Clinical Oncology (127)
  4. Journal of Molecular Diagnostics (94)
  5. Clinical Cancer Research (87)
  6. Journal of Thoracic Oncology (77)

More Publications

Publishers
  1. Nature Publishing Group (225)
  2. American Association for Cancer Research (202)
  3. Nature Research (191)
  4. American Society of Clinical Oncology (152)
  5. Elsevier Science, Inc. (121)
  6. Elsevier Inc. (97)

More Publishers

Results (1336)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In Memoriam William L. Gerald, MD, Ph.D, 1954-2008
    Journal Article

    Ladanyi, M.
    Journal of Molecular Diagnostics (2009)

    Fulltext@MSK | Save
  • EGFR Exon 19 insertions in lung adenocarcinoma
    Meeting Abstract

    He, M.; Nafa, K.; Arcila, M.; Brevet, M.; Oxnard, G.; Miller, V.; Ladanyi, M.
    Journal of Molecular Diagnostics (2009)

    Fulltext@MSK | Save
  • Incidental primary bronchioloalveolar carcinoma-like lesions in young patients with pediatric malignancies: Histopathologic and molecular features
    Meeting Abstract

    He, M.; Zakowski, M. F.; Moreira, A.; Lau, C.; Chou, A. J.; Merchant, M.; Melora, P. R.; Wexler, L. H.; La Quaglia, M. P.; Travis, W. D.; more...
    Modern Pathology (2009)

    Fulltext@MSK | Save
  • Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas thymomas
    Meeting Abstract

    Girard, N.; Shen, R.; Guo, T.; Zakowski, M. F.; Heguy, A.; Riely, G. J.; Huang, J.; Lau, C.; Lash, A.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • BRD4-NUT fusion oncogene analysis by RT PCR in sinonasal undifferentiated carcinoma (SNUC) and other aggressive primary sinonasal malignancies: A study of 15 cases
    Meeting Abstract

    Garcia, J. J.; Nafa, K.; Carlson, D. L.; Barnes, E. L.; Seethala, R. R.; Ladanyi, M.
    Modern Pathology (2009)

    Fulltext@MSK | Save
  • Melanotic XP11 translocation renal cancer: A distinctive neoplasm with overlapping features of pecoma, carcinoma, and melanoma
    Meeting Abstract

    Argani, P.; Aulmann, S.; Karanjawala, Z.; Fraser, R.; Ladanyi, M.; Rodriguez, M.
    Modern Pathology (2009)

    Fulltext@MSK | Save
  • Melanotic Xp11 translocation renal cancers a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma
    Journal Article

    Argani, P.; Aulmann, S.; Karanjawala, Z.; Fraser, R. B.; Ladanyi, M.; Rodriguez, M. M.
    American Journal of Surgical Pathology (2009)

    Fulltext@MSK | Save
  • Improved detection of the EGFR T790M mutation in lung cancer patients with acquired resistance to EGFR TKIs using a locked nucleic acid-based approach
    Meeting Abstract

    Arcila, M. E.; Nafa, K.; Oxnard, G.; Miller, V.; Ladanyi, M.
    Journal of Molecular Diagnostics (2009)

    Fulltext@MSK | Save
  • Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib
    Journal Article

    Zakowski, M. F.; Hussain, S.; Pao, W.; Ladanyi, M.; Ginsberg, M. S.; Heelan, R.; Miller, V. A.; Rusch, V. W.; Kris, M. G.
    Archives of Pathology & Laboratory Medicine (2009)

    Fulltext@MSK | Save
  • The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers
    Journal Article

    Veeriah, S.; Brennan, C.; Meng, S.; Singh, B.; Fagin, J. A.; Solit, D. B.; Paty, P. B.; Rohle, D.; Vivanco, I.; Chmielecki, J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save